Topics

Diffuse midline glioma | Treatment | Case reports | H3K27-Altered

Home > Publications > Topics > Diffuse midline glioma > Treatment > Case reports > H3K27-Altered

Broggi G, Salzano S, Failla M, Barbagallo GMV, Certo F, Zanelli M, Palicelli A, Zizzo M, Koufopoulos N, Magro G, Caltabiano R.
Clinico-Pathological Features of Diffuse Midline Glioma, H3 K27-Altered in Adults: A Comprehensive Review of the Literature with an Additional Single-Institution Case Series.
Diagnostics (Basel). 2024 Nov 21;14(23):2617. doi: 10.3390/diagnostics14232617. PMID: 39682526. Case report; Review. ˍ

Champeaux Depond C, Metellus P, Gross E, Appay R.
Vanishing Contrast Enhancement of a Diffuse Midline Glioma.
Neuropathology. 2025 Feb 19. doi: 10.1111/neup.70002. PMID: 39970957. Case report˰ ˍ

Sumita K, Sawada M, Hattori EY, Sano N, Takada S, Tanji M, Mineharu Y, Kikuchi T, Arakawa Y.
Diffuse midline glioma H3K27-altered with thoracic epidural metastasis: illustrative case.
J Neurosurg Case Lessons. 2025 Jul 14;10(2):CASE25249. doi: 10.3171/CASE25249. PMID: 40658994. Case report. ˍ

Kitagawa Y, Tanaka S, Abe H, Takami H, Hana T, Nomura M, Takayanagi S, Ushiku T, Saito N.
Histologically indolent but widely disseminated diffuse midline glioma H3K27-altered revealed by autopsy.
Brain Tumor Pathol. 2026 Jan 6. doi: 10.1007/s10014-025-00525-z. PMID: 41495345. Case report˰ ˍ

[Despite the use of magnetic resonance imaging to evaluate tumor extension, its microscopic dissemination can extend far beyond radiological detection.]